These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
126 related items for PubMed ID: 4945999
1. Treatment of metastatic Ewing's sarcoma with actinomycin D (NSC-3053). Senyszyn JJ, Johnson RE, Curran RE. Cancer Chemother Rep; 1970 Apr; 54(2):103-7. PubMed ID: 4945999 [No Abstract] [Full Text] [Related]
2. [Ewing's sarcoma localized to the mandible. 2 cases]. Brocheriou C, Guilbert F, Rouchon C, Benoist M, Chikhani P. Rev Stomatol Chir Maxillofac; 1974 Sep; 75(6):877-84. PubMed ID: 4533132 [No Abstract] [Full Text] [Related]
3. Treatment of Ewing's sarcoma with adriamycin (NSC-123127). Oldham RK, Pomeroy TC. Cancer Chemother Rep; 1972 Oct; 56(5):635-9. PubMed ID: 4569057 [No Abstract] [Full Text] [Related]
4. Coordinated treatment of childhood rhabdomyosarcoma with surgery, radiotherapy, and combination chemotherapy. Pratt CB, Hustu HO, Fleming ID, Pinkel D. Cancer Res; 1972 Mar; 32(3):606-10. PubMed ID: 4551437 [No Abstract] [Full Text] [Related]
5. Ewing's sarcoma a study of treatment methods. Jenkin RD. Clin Radiol; 1966 Apr; 17(2):97-106. PubMed ID: 5931313 [No Abstract] [Full Text] [Related]
6. Treatment of Ewing's sarcoma with local irradiation and systemic chemotherapy. A progress report. Johnson RE, Senyszyn JJ, Rabson AS, Peterson KA. Radiology; 1970 Apr; 95(1):195-7. PubMed ID: 4984678 [No Abstract] [Full Text] [Related]
7. Clinical trial of acetylenic carbamate: 1,1-diphenyl-2-propynyl cyclohexanecarbamate (NSC-112682). Gailani S, Blais M. Cancer Chemother Rep; 1970 Jun; 54(3):187-90. PubMed ID: 4334087 [No Abstract] [Full Text] [Related]
8. Protective, elective lung irradiation in non-metastatic Ewing's sarcoma. Marinova L, Hristozova I, Mihaylova I, Perenovska P. Radiat Prot Dosimetry; 2015 Jul; 165(1-4):492-4. PubMed ID: 26113577 [Abstract] [Full Text] [Related]
9. Integrated therapy for Ewing's sarcoma. Johnson RE, Pomeroy TC. Am J Roentgenol Radium Ther Nucl Med; 1972 Mar; 114(3):532-5. PubMed ID: 4622152 [No Abstract] [Full Text] [Related]
10. Low dosage methotrexate (NSC-740) and cyclophosphamide (NSC 26271) for solid tumors. Foley JF, Lemon HM, Miller D. Cancer Chemother Rep; 1970 Feb; 54(1):41-6. PubMed ID: 4334084 [No Abstract] [Full Text] [Related]
11. Evaluation of the combination of hexamethylmelamine (NSC-13875) and methotrexate (NSC-740) in carcinoma of the lung. Weiss AJ, Wilson WL. Cancer Chemother Rep; 1971 Jun; 55(3):299-302. PubMed ID: 5115850 [No Abstract] [Full Text] [Related]
12. Analysis of local tumor control in Ewing's sarcoma: preliminary results of a cooperative intergroup study. Perez CA, Razek A, Tefft M, Nesbit M, Burgert EO, Kissane J, Vietti T, Gehan EA. Cancer; 1977 Dec; 40(6):2864-73. PubMed ID: 338138 [No Abstract] [Full Text] [Related]
13. Evaluation of therapeutic results in Ewing's sarcoma. Johnson RE, Pomeroy TC. Am J Roentgenol Radium Ther Nucl Med; 1975 Mar; 123(3):583-7. PubMed ID: 1124835 [No Abstract] [Full Text] [Related]
14. Ifosfamide and actinomycin-D, added in the induction phase to vincristine, cyclophosphamide and doxorubicin, improve histologic response and prognosis in patients with non metastatic Ewing's sarcoma of the extremity. Ferrari S, Mercuri M, Rosito P, Mancini A, Barbieri E, Longhi A, Rimondini S, Cesari M, Ruggieri P, Di Liddo M, Bacci G. J Chemother; 1998 Dec; 10(6):484-91. PubMed ID: 9876058 [Abstract] [Full Text] [Related]
15. Combination chemotherapy with bleomycin, cyclophosphamide and dactinomycin for the treatment of osteogenic sarcoma. Mosende C, Gutierrez M, Caparros B, Rosen G. Cancer; 1977 Dec; 40(6):2779-86. PubMed ID: 73409 [Abstract] [Full Text] [Related]
16. Evaluation of chemotherapy in children with metastatic Ewing's sarcoma and osteogenic sarcoma. Sutow WW, Vietti TJ, Fernbach DJ, Lane DM, Donaldson MH, Lonsdale D. Cancer Chemother Rep; 1971 Feb; 55(1):67-78. PubMed ID: 5287340 [No Abstract] [Full Text] [Related]
18. Cyclophosphamide-hydroxycamptothecin as second-line chemotherapy for advanced Ewing's sarcoma: experience of a single institution. Han K, Sun Y, Zhang J, He A, Zheng S, Shen Z, Yao Y. Asia Pac J Clin Oncol; 2014 Jun; 10(2):e114-7. PubMed ID: 23176372 [Abstract] [Full Text] [Related]